Major outbreak of toxic shock-like syndrome caused by Streptococcus mitis

Journal of Clinical Microbiology

Volumn 41, Issue 7, 2003, Pages 3051-3055

  Lu, Hong Zhou ^a,b   Weng, Xin Hua ^b   Zhu, Bai ^c   Li, Haijing ^a   Yin, You Kuan ^b   Zhang, Yong Xin ^b   Haas, David W ^a   Tang, Yi Wei ^a,d  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FUDAN UNIVERSITY   (China)

^c Haian People's Hospital   (China)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; RNA 16S;

ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; CONTROLLED STUDY; EPIDEMIC; FEMALE; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MITOGENESIS; MOLECULAR WEIGHT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; RABBIT; SEASONAL VARIATION; SEQUENCE HOMOLOGY; SPLEEN CELL; STREPTOCOCCUS MITIS; THROAT CULTURE; TOXIC SHOCK SYNDROME;

ANIMALS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CHINA; DISEASE OUTBREAKS; DNA, RIBOSOMAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EXOTOXINS; HUMANS; MEMBRANE PROTEINS; PHARYNGITIS; PHENOTYPE; RABBITS; RNA, RIBOSOMAL, 16S; SCARLET FEVER; SEQUENCE ANALYSIS, DNA; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS MITIS;

ANIMALIA; BACTERIA (MICROORGANISMS); ORYCTOLAGUS CUNICULUS; POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS MITIS;

EID: 0037493116     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.7.3051-3055.2003     Document Type: Article

References (40)

1. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
2. Andersen, P. S., P. M. Lavoie, R. P. Sekaly, H. Churchill, D. M. Kranz, P. M. Schlievert, K. Karjalainen, and R. A. Mariuzza. 1999. Role of the T-cell receptor alpha chain in stabilizing TCR-superantigen-MHC class II complexes. Immunity 10:473-483.
3. Anonymous. 1993. Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 269:390-391.
4. Arala-Chaves, M. P., T. B. Higerd, M. T. Porto, J. Munoz, J. M. Goust, H. H. Fudenberg, and C. B. Loadholt. 1979. Evidence for the synthesis and release of strongly immunosuppressive, noncytotoxic substances by Streptococcus intermedius. J. Clin. Investig. 64:871-883.
5. Black, C. M., D. F. Talkington, T. O. Messmer, R. R. Facklam, E. Hornes, and O. Olsvik. 1993. Detection of streptococcal pyrogenic exotoxin genes by a nested polymerase chain reaction. Mol. Cell. Probes 7:255-259.
6. Bohach, G. A., D. J. Fast, R. D. Nelson, and P. M. Schlievert. 1990. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit. Rev. Microbiol. 17:251-272.
7. Braun, M. A., D. Gerlach, U. F. Hartwig, J. H. Ozegowski, F. Romagne, S. Carrel, W. Kohler, and B. Fleischer. 1993. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins). J. Immunol. 150:2457-2466.
8. Brosius, J., M. L. Palmer, P. J. Kennedy, and H. F. Noller. 1978. Complete nucleotide sequence of a 16S ribosomal RNA gene from Escherichia coli. Proc. Natl. Acad. Sci. USA 75:4801-4805.
9. Catto, B. A., M. R. Jacobs, and D. M. Shlaes. 1987. Streptococcus mitis. A cause of serious infection in adults. Arch. Intern. Med. 147:885-888.
10. Cleary, P. P., E. L. Kaplan, J. P. Handley, A. Wlazlo, M. H. Kim, A. R. Hauser, and P. M. Schlievert. 1992. Clonal basis for resurgence of serious Streptococcuspyogenes disease in the 1980s. Lancet 339:518-521.
11. Cone, L. A., D. R. Woodard, P. M. Schlievert, and G. S. Tomory. 1987. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N. Engl. J. Med. 317:146-149.
12. D'Agata, E. M., H. J. Li, C. Gouldin, and Y. W. Tang. 2001. Clinical and molecular characterization of vancomycin-resistant Enterococcus faecium during endemicity. Clin. Infect. Dis. 33:511-516.
13. Elting, L. S., G. P. Bodey, and B. H. Keefe. 1992. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin. Infect. Dis. 14:1201-1207.
14. Fertally, S. S., and R. Facklam. 1987. Comparison of physiologic tests used to identify non-beta-hemolytic aerococci, enterococci, and streptococci. J. Clin. Microbiol. 25:1845-1850.
15. Gerlach, D., K. H. Schmidt, and B. Fleischer. 2001. Basic streptococcal superantigens (SPEX/SMEZ or SPEC) are responsible for the mitogenic activity of the so-called mitogenic factor (MF). FEMS Immunol. Med. Microbiol. 30:209-216.
16. Hanage, W. P., and J. Cohen. 2002. Stimulation of cytokine release and adhesion molecule expression by products of viridans streptococci. J. Infect. Dis. 185:357-367.
17. Kamezawa, Y., T. Nakahara, S. Nakano, Y. Abe, J. Nozaki-Renard, and T. Isono. 1997. Streptococcal mitogenic exotoxin Z, a novel acidic superantigenic toxin produced by a T1 strain of Streptococcus pyogenes. Infect. Immun. 65:3828-3833.
18. Kehoe, M. A., V. Kapur, A. M. Whatmore, and J. M. Musser. 1996. Horizontal gene transfer among group A streptococci: implications for pathogenesis and epidemiology. Trends Microbiol. 4:436-443.
19. Keiser, P., and W. Campbell. 1992. "Toxic strep syndrome" associated with group C streptococcus. Arch. Intern. Med. 152:882-884.
20. Lottenberg, R., C. C. Broder, M. D. Boyle, S. J. Kain, B. L. Schroeder, and R. Curtiss III. 1992. Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor. J. Bacteriol. 174:5204-5210.
21. Lu, H. Z., X. H. Weng, H. Li, Y. K. Yin, M. Y. Pang, and Y. W. Tang. 2002. Enterococcusfaecium-related outbreak with molecular evidence of transmission from pigs to humans. J. Clin. Microbiol. 40:40:913-917.
22. Martin, D. R., and L. A. Single. 1993. Molecular epidemiology of group A streptococcus M type 1 infections. J. Infect. Dis. 167:1112-1117.
23. Matsushita, K., W. Fujimaki, H. Kato, T. Uchiyama, H. Igarashi, H. Ohkuni, S. Nagaoka, M. Kawagoe, S. Kotani, and H. Takada. 1995. Immunopathological activities of extracellular products of Streptococcus mitis, particularly a superantigenic fraction. Infect. Immun. 63:785-793.
24. McCormick, J. K., A. A. Pragman, J. C. Stolpa, D. Y. Leung, and P. M. Schlievert. 2001. Functional characterization of streptococcal pyrogenic exotoxin J, a novel superantigen. Infect. Immun. 69:1381-1388.
25. Murono, K., K. Fujita, M. Saijo, Y. Hirano, J. Zhang, and T. Murai. 1999. Emergence and spread of a new clone of M type 1 group A Streptococcus coincident with the increase in invasive diseases in Japan. Pediatr. Infect. Dis. J. 18:254-257.
26. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard M100-S10. National Committee for Clinical Laboratory Standards, Wayne, Pa.
27. Pratter, M. R., and R. S. Irwin. 1980. Viridans streptococcal pulmonary parenchymal infections. JAMA 243:2515-2517.
28. Proft, T., V. L. Arcus, V. Handley, E. N. Baker, and J. D. Fraser. 2001. Immunological and biochemical characterization of streptococcal pyrogenic exotoxins I and J (SPE-I and SPE-J) from Streptococcus pyogenes. J. Immunol. 166:6711-6719.
29. Schlievert, P. M., K. M. Bettin, and D. W. Watson. 1978. Effect of antipyretics on group A streptococcal pyrogenic exotoxin fever production and ability to enhance lethal endotoxin shock. Proc. Soc. Exp. Biol. Med. 157:472-475.
30. Schlievert, P. M., J. E. Gocke, and J. R. Deringer. 1993. Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin. Clin. Infect. Dis. 17:26-31.
31. Smith, G. P., and J. K. Scott. 1993. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol. 217:228-257.
32. Soto, A., P. H. McWhinney, C. C. Kibbler, and J. Cohen. 1998. Cytokine release and mitogenic activity in the viridans streptococcal shock syndrome. Cytokine 10:370-376.
33. Sriskandan, S., M. Unnikrishnan, T. Krausz, and J. Cohen. 1999. Molecular analysis of the role of streptococcal pyrogenic exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes. Mol. Microbiol. 33:778-790.
34. Stevens, D. L., M. H. Tanner, J. Winship, R. Swarts, K. M. Ries, P. M. Schlievert, and E. Kaplan. 1989. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med. 321:1-7.
35. Sussman, J. I., E. J. Baron, M. J. Tenenbaum, M. H. Kaplan, J. Greenspan, R. R. Facklam, M. B. Tyburski, M. A. Goldman, B. F. Kanzer, and R. A. Pizzarello. 1986. Viridans streptococcal endocarditis: clinical, microbiological, and echocardiographic correlations. J. Infect. Dis. 154:597-603.
36. Talkington, D. F., B. Schwartz, C. M. Black, J. K. Todd, J. Elliott, R. F. Breiman, and R. R. Facklam. 1993. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect. Immun. 61:3369-3374.
37. Tang, Y. W., N. M. Ellis, M. K. Hopkins, D. H. Smith, D. E. Dodge, and D. H. Persing. 1998. Comparison of phenotypic and genotypic techniques for identification of unusual aerobic pathogenic gram-negative bacilli. J. Clin. Microbiol. 36:3674-3679.
38. Tang, Y. W., M. K. Hopkins, C. P. Kolbert, P. A. Hartley, P. J. Severance, and D. H. Persing. 1998. Bordetella holmesii-like organisms associated with septicemia, endocarditis, and respiratory failure. Clin. Infect. Dis. 26:389-392.
39. Willoughby, R., and R. N. Greenberg. 1983. The toxic shock syndrome and streptococcal pyrogenic exotoxins. Ann. Intern. Med. 98:559.
40. Zhu, B., G. H. Wang, X. H. Sun, Z. G. Luu, Z. Mao, X. N. Jiang, Y. K. Yin, S. F. Guo, and F. X. Lin. 1993. Clinical and experimental studies on scarlet fever associated with Streptococcus mitis. Chinese J. Infect. Dis. 11:68-70.